{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:38:58Z","timestamp":1769575138232,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11686-024-00897-w","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:42:58Z","timestamp":1727185378000},"page":"1811-1818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MicroRNA Guided In Silico Drug Repositioning for Malaria"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2694-4857","authenticated-orcid":false,"given":"Sowmya R.","family":"Prabhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3783-8291","authenticated-orcid":false,"given":"Akshay Pramod","family":"Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-5490","authenticated-orcid":false,"given":"Kapaettu","family":"Satyamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4151-9584","authenticated-orcid":false,"given":"Abdul Vahab","family":"Saadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"897_CR1","unstructured":"World Health Organisation (WHO) (2022) Malaria. https:\/\/www.who.int\/health-topics\/malaria#tab=tab_1 (Accessed on 11 November 2022)"},{"issue":"2","key":"897_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/14760584.2019.1561289","volume":"18","author":"KL Wilson","year":"2019","unstructured":"Wilson KL, Flanagan KL, Prakash MD, Plebanski M (2019a) Malaria vaccines in the eradication era: current status and future perspectives. Expert Rev Vaccines 18(2):133\u2013151. https:\/\/doi.org\/10.1080\/14760584.2019.1561289","journal-title":"Expert Rev Vaccines"},{"key":"897_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fimmu.2019.00331","volume":"10","author":"KL Wilson","year":"2019","unstructured":"Wilson KL, Pouniotis D, Hanley J, Xiang SD, Ma C, Coppel RL, Plebanski M (2019b) A synthetic nanoparticle based Vaccine Approach Targeting MSP4\/5 is immunogenic and induces Moderate Protection against Murine Blood-Stage Malaria. Front Immunol 10:331. https:\/\/doi.org\/10.3389\/fimmu.2019.00331","journal-title":"Front Immunol"},{"issue":"3","key":"897_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","volume":"16","author":"MB Laurens","year":"2020","unstructured":"Laurens MB (2020) RTS,S\/AS01 vaccine (Mosquirix\u2122): an overview. Hum Vaccin Immunother 16(3):480\u2013489. https:\/\/doi.org\/10.1080\/21645515.2019.1669415","journal-title":"Hum Vaccin Immunother"},{"issue":"1579","key":"897_CR5","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1098\/rstb.2011.0091","volume":"366","author":"AV Hill","year":"2011","unstructured":"Hill AV (2011) Vaccines against malaria. Philos Trans R Soc Lond B Biol Sci 366(1579):2806\u20132814. https:\/\/doi.org\/10.1098\/rstb.2011.0091","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"897_CR6","unstructured":"World Health Organisation (WHO) (2021) WHO recommends groundbreaking malaria vaccine for children at risk. https:\/\/www.who.int\/news\/item\/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk (Accessed on 10 November 2022)"},{"issue":"10","key":"897_CR7","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nbt1015-1015","volume":"33","author":"C Morrison","year":"2015","unstructured":"Morrison C (2015) Landmark green light for Mosquirix malaria vaccine. Nat Biotechnol 33(10):1015\u20131016. https:\/\/doi.org\/10.1038\/nbt1015-1015","journal-title":"Nat Biotechnol"},{"issue":"6","key":"897_CR8","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/emmm.201403876","volume":"6","author":"I Delany","year":"2014","unstructured":"Delany I, Rappuoli R, De Gregorio E (2014) Vaccines for the 21st century. EMBO Mol Med 6(6):708\u2013720. https:\/\/doi.org\/10.1002\/emmm.201403876","journal-title":"EMBO Mol Med"},{"key":"897_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2018.05.006","volume":"42","author":"R van Hooft","year":"2018","unstructured":"van Hooft R, Wells TN (2018) The antimalarial pipeline. Curr Opin Pharmacol 42:1\u20136. https:\/\/doi.org\/10.1016\/j.coph.2018.05.006","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"897_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s40265-018-0911-9","volume":"78","author":"EA Ashley","year":"2018","unstructured":"Ashley EA, Phyo AP (2018) Drugs in development for Malaria. Drugs 78(9):861\u2013879. https:\/\/doi.org\/10.1007\/s40265-018-0911-9","journal-title":"Drugs"},{"key":"897_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/B978-0-444-62652-3.00003-X","volume":"52","author":"F Calder\u00f3n","year":"2013","unstructured":"Calder\u00f3n F, Wilson DM, Gamo FJ (2013) Antimalarial drug discovery: recent progress and future directions. Prog Med Chem 52:97\u2013151. https:\/\/doi.org\/10.1016\/B978-0-444-62652-3.00003-X","journal-title":"Prog Med Chem"},{"issue":"33","key":"897_CR12","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.2174\/09298673113209990198","volume":"20","author":"S Zhou","year":"2013","unstructured":"Zhou S, Wang F, Hsieh TC, Wu JM, Wu E (2013) Thalidomide-a notorious sedative to a wonder anticancer drug. Curr Med Chem 20(33):4102\u20134108. https:\/\/doi.org\/10.2174\/09298673113209990198","journal-title":"Curr Med Chem"},{"issue":"8","key":"897_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrd2030","volume":"5","author":"HA Ghofrani","year":"2006","unstructured":"Ghofrani HA, Osterloh IH, Grimminger F (2006) Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov 5(8):689\u2013702. https:\/\/doi.org\/10.1038\/nrd2030","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"897_CR14","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3109\/10717544.2014.951746","volume":"23","author":"A Kumar","year":"2016","unstructured":"Kumar A, Naguib YW, Shi YC, Cui Z (2016) A method to improve the efficacy of topical eflornithine hydrochloride cream. Drug Delivery 23(5):1495\u20131501. https:\/\/doi.org\/10.3109\/10717544.2014.951746","journal-title":"Drug Delivery"},{"key":"897_CR15","doi-asserted-by":"publisher","unstructured":"Priotto G, Pinoges L, Fursa IB, Burke B, Nicolay N, Grillet G, Hewison C, Balasegaram M (2008) Safety and effectiveness of first line eflornithine for Trypanosoma Brucei gambiense sleeping sickness in Sudan: cohort study. BMJ (clinical research ed. 336(7646):705\u2013708. https:\/\/doi.org\/10.1136\/bmj.39485.592674.BE","DOI":"10.1136\/bmj.39485.592674.BE"},{"issue":"1","key":"897_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41598-020-80722-2","volume":"11","author":"BN Diallo","year":"2021","unstructured":"Diallo BN, Swart T, Hoppe HC, Tastan Bishop \u00d6, Lobb K (2021) Potential repurposing of four FDA approved compounds with antiplasmodial activity identified through proteome scale computational drug discovery and in vitro assay. Sci Rep 11(1):1413. https:\/\/doi.org\/10.1038\/s41598-020-80722-2","journal-title":"Sci Rep"},{"issue":"6","key":"897_CR17","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/molecules25061375","volume":"25","author":"X Lin","year":"2020","unstructured":"Lin X, Li X, Lin X (2020) A review on applications of computational methods in drug screening and design. Molecules 25(6):1375. https:\/\/doi.org\/10.3390\/molecules25061375","journal-title":"Molecules"},{"key":"897_CR18","doi-asserted-by":"publisher","first-page":"406463","DOI":"10.1155\/2015\/406463","volume":"2015","author":"H Chen","year":"2015","unstructured":"Chen H, Zhang Z (2015) A miRNA-driven inference model to construct potential drug-disease associations for drug repositioning. Biomed Res Int 2015:406463. https:\/\/doi.org\/10.1155\/2015\/406463","journal-title":"Biomed Res Int"},{"issue":"8","key":"897_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.molmed.2011.04.003","volume":"17","author":"JL Rukov","year":"2011","unstructured":"Rukov JL, Shomron N (2011) MicroRNA pharmacogenomics: post-transcriptional regulation of drug response. Trends Mol Med 17(8):412\u2013423. https:\/\/doi.org\/10.1016\/j.molmed.2011.04.003","journal-title":"Trends Mol Med"},{"issue":"2","key":"897_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/bib\/bbz012","volume":"21","author":"X Zhou","year":"2020","unstructured":"Zhou X, Dai E, Song Q, Ma X, Meng Q, Jiang Y, Jiang W (2020) In silico drug repositioning based on drug-miRNA associations. Brief Bioinform 21(2):498\u2013510. https:\/\/doi.org\/10.1093\/bib\/bbz012","journal-title":"Brief Bioinform"},{"issue":"3","key":"897_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/bioinformatics\/bts698","volume":"29","author":"X Liu","year":"2013","unstructured":"Liu X, Wang S, Meng F, Wang J, Zhang Y, Dai E, Yu X, Li X, Jiang W (2013) SM2miR: a database of the experimentally validated small molecules\u2019 effects on microRNA expression. Bioinf (Oxford England) 29(3):409\u2013411. https:\/\/doi.org\/10.1093\/bioinformatics\/bts698","journal-title":"Bioinf (Oxford England)"},{"issue":"4","key":"897_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/bib\/bbs082","volume":"15","author":"JL Rukov","year":"2014","unstructured":"Rukov JL, Wilentzik R, Jaffe I, Vinther J, Shomron N (2014) Pharmaco-miR: linking microRNAs and drug effects. Brief Bioinform 15(4):648\u2013659. https:\/\/doi.org\/10.1093\/bib\/bbs082","journal-title":"Brief Bioinform"},{"issue":"D1","key":"897_CR23","doi-asserted-by":"publisher","first-page":"D1013","DOI":"10.1093\/nar\/gky1010","volume":"47","author":"Z Huang","year":"2019","unstructured":"Huang Z, Shi J, Gao Y, Cui C, Zhang S, Li J, Zhou Y, Cui Q (2019) HMDD v3.0: a database for experimentally supported human microRNA-disease associations. Nucleic Acids Res 47(D1):D1013\u2013D1017. https:\/\/doi.org\/10.1093\/nar\/gky1010","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"897_CR24","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2021","unstructured":"Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, Mattingly CJ (2021) Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res 49(D1):D1138\u2013D1143. https:\/\/doi.org\/10.1093\/nar\/gkaa891","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"897_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/bioinformatics\/btm554","volume":"24","author":"Y Assenov","year":"2008","unstructured":"Assenov Y, Ram\u00edrez F, Schelhorn SE, Lengauer T, Albrecht M (2008) Computing topological parameters of biological networks. Bioinf (Oxford England) 24(2):282\u2013284. https:\/\/doi.org\/10.1093\/bioinformatics\/btm554","journal-title":"Bioinf (Oxford England)"},{"key":"897_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/srep00282","volume":"2","author":"W Jiang","year":"2012","unstructured":"Jiang W, Chen X, Liao M, Li W, Lian B, Wang L, Meng F, Liu X, Chen X, Jin Y, Li X (2012) Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses. Sci Rep 2:282. https:\/\/doi.org\/10.1038\/srep00282","journal-title":"Sci Rep"},{"issue":"25","key":"897_CR27","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.1002\/anie.201302116","volume":"52","author":"B Kobilka","year":"2013","unstructured":"Kobilka B (2013) The structural basis of G-protein-coupled receptor signaling (Nobel lecture). Angew Chem Int Ed Engl 52(25):6380\u20136388. https:\/\/doi.org\/10.1002\/anie.201302116","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5640","key":"897_CR28","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1126\/science.1089324","volume":"301","author":"T Harrison","year":"2003","unstructured":"Harrison T, Samuel BU, Akompong T, Hamm H, Mohandas N, Lomasney JW, Haldar K (2003) Erythrocyte G protein-coupled receptor signaling in malarial infection. Science 301(5640):1734\u20131736. https:\/\/doi.org\/10.1126\/science.1089324","journal-title":"Science"},{"issue":"12","key":"897_CR29","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1371\/journal.pmed.0030528","volume":"3","author":"SC Murphy","year":"2006","unstructured":"Murphy SC, Harrison T, Hamm HE, Lomasney JW, Mohandas N, Haldar K (2006) Erythrocyte G protein as a novel target for malarial chemotherapy. PLoS Med 3(12):e528. https:\/\/doi.org\/10.1371\/journal.pmed.0030528","journal-title":"PLoS Med"},{"issue":"1","key":"897_CR30","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1038\/s41467-018-06986-5","volume":"9","author":"L Vandermosten","year":"2018","unstructured":"Vandermosten L, Pham TT, Knoops S, De Geest C, Lays N, Van der Molen K, Kenyon CJ, Verma M, Chapman KE, Schuit F, De Bosscher K, Opdenakker G, Van den Steen PE (2018) Adrenal hormones mediate disease tolerance in malaria. Nat Commun 9(1):4525. https:\/\/doi.org\/10.1038\/s41467-018-06986-5","journal-title":"Nat Commun"},{"issue":"4","key":"897_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1051\/parasite\/2004114343","volume":"11","author":"S Bertani","year":"2004","unstructured":"Bertani S, Gantier JC, Chabaud A, Landau I (2004) Action of adrenalin on the circulation of the murine Plasmodium developing stages, in different blood compartments. Parasite (Paris France) 11(4):343\u2013350. https:\/\/doi.org\/10.1051\/parasite\/2004114343","journal-title":"Parasite (Paris France)"},{"issue":"6","key":"897_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1747-0285.2006.00391.x","volume":"67","author":"JL Weisman","year":"2006","unstructured":"Weisman JL, Liou AP, Shelat AA, Cohen FE, Guy RK, DeRisi JL (2006) Searching for new antimalarial therapeutics amongst known drugs. Chem Biol Drug Des 67(6):409\u2013416. https:\/\/doi.org\/10.1111\/j.1747-0285.2006.00391.x","journal-title":"Chem Biol Drug Des"},{"issue":"21","key":"897_CR33","doi-asserted-by":"publisher","first-page":"7477","DOI":"10.1021\/jm2005546","volume":"54","author":"DJ Lowes","year":"2011","unstructured":"Lowes DJ, Guiguemde WA, Connelly MC, Zhu F, Sigal MS, Clark JA, Lemoff AS, Derisi JL, Wilson EB, Guy RK (2011) Optimization of propafenone analogues as antimalarial leads. J Med Chem 54(21):7477\u20137485. https:\/\/doi.org\/10.1021\/jm2005546","journal-title":"J Med Chem"},{"issue":"8","key":"897_CR34","doi-asserted-by":"publisher","first-page":"e6536","DOI":"10.1371\/journal.pone.0006536","volume":"4","author":"G Hu","year":"2009","unstructured":"Hu G, Agarwal P (2009) Human disease-drug network based on genomic expression profiles. PLoS ONE 4(8):e6536. https:\/\/doi.org\/10.1371\/journal.pone.0006536","journal-title":"PLoS ONE"},{"issue":"2","key":"897_CR35","doi-asserted-by":"publisher","first-page":"e87864","DOI":"10.1371\/journal.pone.0087864","volume":"9","author":"H Ye","year":"2014","unstructured":"Ye H, Liu Q, Wei J (2014) Construction of drug network based on side effects and its application for drug repositioning. PLoS ONE 9(2):e87864. https:\/\/doi.org\/10.1371\/journal.pone.0087864","journal-title":"PLoS ONE"},{"issue":"18","key":"897_CR36","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.3390\/ijms20184574","volume":"20","author":"PHM Torres","year":"2019","unstructured":"Torres PHM, Sodero ACR, Jofily P, Silva-Jr FP (2019) Key topics in Molecular Docking for Drug Design. Int J Mol Sci 20(18):4574. https:\/\/doi.org\/10.3390\/ijms20184574","journal-title":"Int J Mol Sci"},{"issue":"5","key":"897_CR37","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/bib\/bbx017","volume":"19","author":"M Lotfi Shahreza","year":"2018","unstructured":"Lotfi Shahreza M, Ghadiri N, Mousavi SR, Varshosaz J, Green JR (2018) A review of network-based approaches to drug repositioning. Brief Bioinform 19(5):878\u2013892. https:\/\/doi.org\/10.1093\/bib\/bbx017","journal-title":"Brief Bioinform"},{"issue":"12","key":"897_CR38","doi-asserted-by":"publisher","first-page":"e0039222","DOI":"10.1128\/aac.00392-22","volume":"66","author":"A Chaurasiya","year":"2022","unstructured":"Chaurasiya A, Kumari G, Garg S, Shoaib R, Anam Z, Joshi N, Kumari J, Singhal J, Singh N, Kaushik S, Kahlon AK, Dubey N, Maurya MK, Srivastava P, Marothia M, Joshi P, Gupta K, Saini S, Das G, Bhattacharjee S, Ranganathan A (2022) Targeting artemisinin-resistant malaria by repurposing the Anti-hepatitis C Virus Drug Alisporivir. Antimicrob Agents Chemother 66(12):e0039222. https:\/\/doi.org\/10.1128\/aac.00392-22","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"897_CR39","doi-asserted-by":"publisher","first-page":"e30533","DOI":"10.1002\/jcb.30533","volume":"125","author":"K Verma","year":"2024","unstructured":"Verma K, Chaturvedi R, Lahariya AK, Verma AK, Schneider KA, Anvikar AR, Bharti PK (2024) Repurposing FDA-approved drugs to target malaria through inhibition of dihydrofolate reductase in the folate biosynthesis pathway: a prospective approach. J Cell Biochem 125(3):e30533. https:\/\/doi.org\/10.1002\/jcb.30533","journal-title":"J Cell Biochem"},{"issue":"2","key":"897_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10142-023-01028-w","volume":"23","author":"SR Prabhu","year":"2023","unstructured":"Prabhu SR, Ware AP, Umakanth S, Hande M, Mahabala C, Saadi AV, Satyamoorthy K (2023) Erythrocyte miRNA-92a-3p interactions with PfEMP1 as determinants of clinical malaria. Funct Integr Genom 23(2):93. https:\/\/doi.org\/10.1007\/s10142-023-01028-w","journal-title":"Funct Integr Genom"},{"issue":"10","key":"897_CR41","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1021\/acschembio.5b00265","volume":"10","author":"CL Haga","year":"2015","unstructured":"Haga CL, Velagapudi SP, Strivelli JR, Yang WY, Disney MD, Phinney DG (2015) Small molecule inhibition of miR-544 Biogenesis disrupts adaptive responses to Hypoxia by modulating ATM-mTOR Signaling. ACS Chem Biol 10(10):2267\u20132276. https:\/\/doi.org\/10.1021\/acschembio.5b00265","journal-title":"ACS Chem Biol"},{"key":"897_CR42","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.omtn.2018.12.002","volume":"14","author":"J Qu","year":"2019","unstructured":"Qu J, Chen X, Sun YZ, Zhao Y, Cai SB, Ming Z, You ZH, Li JQ (2019) Silico Prediction of Small Molecule-miRNA associations based on the HeteSim Algorithm. Molecular therapy. Nucleic Acids 14:274\u2013286. https:\/\/doi.org\/10.1016\/j.omtn.2018.12.002","journal-title":"Nucleic Acids"},{"key":"897_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.meegid.2013.08.026","volume":"20","author":"AV Saadi","year":"2013","unstructured":"Saadi AV, Gupta H, Angural A, Dhanya SK, Mony S, Oberoi D, D\u2019Souza SC, Sahoo RC, Hande MH, Gopinath PM, Satyamoorthy K (2013) Single nucleotide polymorphisms of ADRB2 gene and their association with susceptibility for Plasmodium Falciparum malaria and asthma in an Indian population. Infect Genet Evol 20:140\u2013147. https:\/\/doi.org\/10.1016\/j.meegid.2013.08.026","journal-title":"Infect Genet Evol"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00897-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-024-00897-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00897-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T15:12:02Z","timestamp":1734361922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-024-00897-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1007\/s11686-024-00897-w","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"4 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not involve any animal study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no conflict of interest, financial or otherwise.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}